smal

  1. T

    Angiotech Announces Long-Term Data Show Advantages For Taxus® Liberté® Stent In Smal

    Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) announced that its corporate partner, Boston Scientific Corporation (NYSE: BSX), has released comprehensive data from the TAXUS ATLAS clinical program, a series of global, prospective, singlearm trials evaluating the TAXUS® Liberté®...
  2. T

    Health Reform Implementation Issues: Emergency Room Costs, Consumer Websites And Smal

    Kaiser Health News: The new health reform law guarantees insurance companies must cover emergency care for their beneficiaries at hospitals in- or out-of-network at the same rate. "The law also bars health plans from requiring prior authorization for emergency services. And it mandates that...
Back
Top